Gabor Abellan van Kan

Summary

Country: France

Publications

  1. ncbi request reprint Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force
    G Abellan Van Kan
    Gerontopole, Department of Geriatric Medicine, Toulouse University Hospital, Toulouse, France
    J Nutr Health Aging 13:881-9. 2009
  2. doi request reprint Sarcopenia and cognitive impairment in elderly women: results from the EPIDOS cohort
    Gabor Abellan van Kan
    Gérontopôle de Toulouse, Department of Geriatric Medicine, Toulouse University Hospital, 170, avenue de Casselardit, Toulouse 31059, France
    Age Ageing 42:196-202. 2013
  3. doi request reprint Gait speed, body composition, and dementia. The EPIDOS-Toulouse cohort
    Gabor Abellan van Kan
    Department of Geriatric Medicine, Toulouse University Hospital, Toulouse, France
    J Gerontol A Biol Sci Med Sci 67:425-32. 2012
  4. doi request reprint Cardiovascular disease risk factors and progression of Alzheimer's disease
    Gabor Abellan van Kan
    INSERM U558, Department of Geriatric Medicine, CHU Toulouse, Toulouse, France
    Dement Geriatr Cogn Disord 27:240-6. 2009
  5. doi request reprint Clinical trials on sarcopenia: methodological issues regarding phase 3 trials
    Gabor Abellan van Kan
    Gerontopole, Department of Geriatric Medicine, Toulouse University Hospital, France
    Clin Geriatr Med 27:471-82. 2011
  6. ncbi request reprint The geriatric minimum data set for clinical trials (GMDS)
    G Abellan Van Kan
    Inserum U558, Department of Geriatric Medicine, CHU Toulouse, France
    J Nutr Health Aging 12:197-200. 2008
  7. ncbi request reprint The I.A.N.A Task Force on frailty assessment of older people in clinical practice
    G Abellan Van Kan
    Department of Geriatric Medicine, Pavillon J P Junod, CHU Toulouse, 170 avenue de Casselardit, TSA40031, 31059 Toulouse Cedex 9, France
    J Nutr Health Aging 12:29-37. 2008
  8. ncbi request reprint GerontoNet: a network of excellence for clinical trials with geriatric patients
    G Abellan Van Kan
    G Abellan van Kan, Department of Geriatric Medicine, 170, Av de Casselardit, CHU Toulouse, France email
    J Nutr Health Aging 11:251-3; discussion 250. 2007
  9. doi request reprint The assessment of frailty in older adults
    Gabor Abellan van Kan
    Gérontopôle de Toulouse, Department of Geriatric Medicine, Pavillon JP Junod, University Hospital Toulouse, CHU Toulouse, 170 avenue de Casselardit, TSA 40031, 31059 Toulouse Cedex 9, France
    Clin Geriatr Med 26:275-86. 2010
  10. doi request reprint Weight loss and rapid cognitive decline in community-dwelling patients with Alzheimer's disease
    Maria E Soto
    Alzheimer s Disease Research and Clinical Centre, Department of Geriatric Medicine, Gerontopole, Toulouse University Hospital, Toulouse, France
    J Alzheimers Dis 28:647-54. 2012

Collaborators

Detail Information

Publications32

  1. ncbi request reprint Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force
    G Abellan Van Kan
    Gerontopole, Department of Geriatric Medicine, Toulouse University Hospital, Toulouse, France
    J Nutr Health Aging 13:881-9. 2009
    ....
  2. doi request reprint Sarcopenia and cognitive impairment in elderly women: results from the EPIDOS cohort
    Gabor Abellan van Kan
    Gérontopôle de Toulouse, Department of Geriatric Medicine, Toulouse University Hospital, 170, avenue de Casselardit, Toulouse 31059, France
    Age Ageing 42:196-202. 2013
    ..common pathophysiological pathways are shared between age-related body composition changes and cognitive impairment...
  3. doi request reprint Gait speed, body composition, and dementia. The EPIDOS-Toulouse cohort
    Gabor Abellan van Kan
    Department of Geriatric Medicine, Toulouse University Hospital, Toulouse, France
    J Gerontol A Biol Sci Med Sci 67:425-32. 2012
    ..The aim of the study was to evaluate whether GS, TLM, and TFM were associated factors with an increased risk for subsequent dementia in community-dwelling older women...
  4. doi request reprint Cardiovascular disease risk factors and progression of Alzheimer's disease
    Gabor Abellan van Kan
    INSERM U558, Department of Geriatric Medicine, CHU Toulouse, Toulouse, France
    Dement Geriatr Cogn Disord 27:240-6. 2009
    ..To assess if cardiovascular disease risk factors (CVDRF) are predictive factors for poorer evolution of Alzheimer's disease (AD) patients in terms of cognitive decline...
  5. doi request reprint Clinical trials on sarcopenia: methodological issues regarding phase 3 trials
    Gabor Abellan van Kan
    Gerontopole, Department of Geriatric Medicine, Toulouse University Hospital, France
    Clin Geriatr Med 27:471-82. 2011
    ..The challenges to conduct phase 3 trials in the elderly should not offset the opportunities for the development of new strategies to counteract sarcopenia and prevent late-life disability...
  6. ncbi request reprint The geriatric minimum data set for clinical trials (GMDS)
    G Abellan Van Kan
    Inserum U558, Department of Geriatric Medicine, CHU Toulouse, France
    J Nutr Health Aging 12:197-200. 2008
    ..This will lead to uniform nomenclature and to the standardisation of the assessment tools. Our primary objective was to develop a Geriatric Minimum Data Set (GMDS) for clinical research...
  7. ncbi request reprint The I.A.N.A Task Force on frailty assessment of older people in clinical practice
    G Abellan Van Kan
    Department of Geriatric Medicine, Pavillon J P Junod, CHU Toulouse, 170 avenue de Casselardit, TSA40031, 31059 Toulouse Cedex 9, France
    J Nutr Health Aging 12:29-37. 2008
    ....
  8. ncbi request reprint GerontoNet: a network of excellence for clinical trials with geriatric patients
    G Abellan Van Kan
    G Abellan van Kan, Department of Geriatric Medicine, 170, Av de Casselardit, CHU Toulouse, France email
    J Nutr Health Aging 11:251-3; discussion 250. 2007
  9. doi request reprint The assessment of frailty in older adults
    Gabor Abellan van Kan
    Gérontopôle de Toulouse, Department of Geriatric Medicine, Pavillon JP Junod, University Hospital Toulouse, CHU Toulouse, 170 avenue de Casselardit, TSA 40031, 31059 Toulouse Cedex 9, France
    Clin Geriatr Med 26:275-86. 2010
    ..The evaluation of gait speed over a short distance emerges from the literature as a tool with the capacity to identify frail older adults, and slow gait speed has been proven to be a strong predictor for frailty-adverse outcomes...
  10. doi request reprint Weight loss and rapid cognitive decline in community-dwelling patients with Alzheimer's disease
    Maria E Soto
    Alzheimer s Disease Research and Clinical Centre, Department of Geriatric Medicine, Gerontopole, Toulouse University Hospital, Toulouse, France
    J Alzheimers Dis 28:647-54. 2012
    ..50, 95% CI = 1.04-2.17). In conclusion, weight loss predicted RCD in this cohort. Whether the prevention of weight loss (by improving nutritional status) impacts cognitive decline remains an open question...
  11. doi request reprint An abnormal "one-leg balance" test predicts cognitive decline during Alzheimer's disease
    Yves Rolland
    INSERM, U558, Toulouse, France
    J Alzheimers Dis 16:525-31. 2009
    ..8 (0.3) points at two years (p < 0.001). An abnormal one-leg balance test is a marker of more advanced dementia and predicts a higher rate of cognitive decline...
  12. doi request reprint Patterns of dementia treatment use in assisted living facilities: a cross-sectional study of 1975 demented residents
    Nadège Barro-Belaygues
    Gérontopôle de Toulouse, Department of Geriatric Medicine, Toulouse University Hospital, Toulouse, France
    J Am Med Dir Assoc 12:648-54. 2011
    ..To report the associated factors with the nonuse of cholinesterase-inhibitors and memantine in residents from assisted living (AL) facilities suffering from dementia...
  13. doi request reprint Gait and balance impairments in Alzheimer disease patients
    Virginia Mazoteras Muñoz
    Department of Geriatric Medicine, Univ Toulouse III, Toulouse, France
    Alzheimer Dis Assoc Disord 24:79-84. 2010
    ..To describe the characteristics and associated factors of Alzheimer disease (AD) patients with balance and gait impairments...
  14. doi request reprint Associated factors with antipsychotic use in assisted living facilities: a cross-sectional study of 4367 residents
    Agnes Larrayadieu
    Department of Geriatric Medicine, Toulouse University Hospital Gérontopôle, 170, avenue de Casselardit, Toulouse 31059, France
    Age Ageing 40:368-75. 2011
    ..Even more, the prescription of these drugs is gradually increasing since the availability of second-generation atypical antipsychotics. More knowledge is needed on prescription reasons to understand this increasing prevalence...
  15. doi request reprint Healthy brain aging: role of exercise and physical activity
    Yves Rolland
    INSERM U558, Avenue J Guesdes, F 31073 Toulouse, France
    Clin Geriatr Med 26:75-87. 2010
    ..Future prevention of Alzheimer disease may depend on lifestyle habits such as physical activity...
  16. doi request reprint Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l'OSteoporose) Study
    Yves Rolland
    Service de Medecine Interne et de Gerontologie Clinique, Hopital La Grave Casselardit, Toulouse, France
    Am J Clin Nutr 89:1895-900. 2009
    ..In elders, decreased muscle mass (sarcopenia) and increased fat mass (obesity) may contribute to difficulties with physical function...
  17. doi request reprint Prognosis of an abnormal one-leg balance in community-dwelling patients with Alzheimer's disease: a 2-year prospective study in 686 patients of the REAL.FR study
    Sandrine Sourdet
    Internal Medicine Service and Gerontology Clinic, Hopital La Grave Casselardit, Toulouse, France
    J Am Med Dir Assoc 13:407.e1-6. 2012
    ..The aim of this study was to explore the predictive value of an abnormal one-leg balance (OLB) test for functional decline, nursing home admission, and mortality in community-dwelling patients affected with Alzheimer's disease (AD)...
  18. doi request reprint Current and future pharmacologic treatment of sarcopenia
    Yves Rolland
    INSERM U1027, University of Toulouse III, Avenue Jules Guesdes, France
    Clin Geriatr Med 27:423-47. 2011
    ..Therefore, new pharmacologic agents may substantially reduce the functional decline in older people. This article reviews the new pharmacologic agents currently being assessed for treating sarcopenia...
  19. doi request reprint Treatment strategies for sarcopenia and frailty
    Yves Rolland
    INSERM U1027, F 31073, Avenue Jules Guesdes, University of Toulouse III, F 31073, France
    Med Clin North Am 95:427-38, ix. 2011
    ..The quality of amino acids in the diet is an important factor for stimulating protein synthesis. Vitamin D deficiency should be treated, and new pharmacologic approaches for sarcopenia are currently assessed...
  20. ncbi request reprint PUFA for prevention and treatment of dementia?
    I Carrie
    Gerontopole, CHU Toulouse, Department of Geriatric Medicine, Toulouse, France
    Curr Pharm Des 15:4173-85. 2009
    ..In this review, we summarize preclinical and clinical research suggesting that DHA exerts beneficial effects on cognitive function with ageing...
  21. ncbi request reprint IANA task force on nutrition and cognitive decline with aging
    S Gillette Guyonnet
    Service de Medecine Interne et de Gerontologie Clinique, Pavillon J P Junod, Centre Hospitalier Universitaire La Grave Casselardit, Toulouse Cedex 9, France
    J Nutr Health Aging 11:132-52. 2007
    ..These studies must control for the greatest number of known confounding factors and take into account the impact of the standard social determinants of food habits, such as the regional cultures, social status, and educational level...
  22. ncbi request reprint Frailty, osteoporosis and hip fracture: causes, consequences and therapeutic perspectives
    Y Rolland
    INSERM U558, F 31073, Universite de Toulouse III, France
    J Nutr Health Aging 12:335-46. 2008
    ..It also sets out to heighten awareness of the need for management of osteoporosis in the frail elderly...
  23. ncbi request reprint Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives
    Y Rolland
    INSERM U558, F 31073Toulouse, France
    J Nutr Health Aging 12:433-50. 2008
    ..On-going and future clinical trials on sarcopenia may radically change our preventive and therapeutic approaches of mobility disability in older people...
  24. ncbi request reprint Descriptive study of nursing home residents from the REHPA network
    Y Rolland
    Gérontopôle de Toulouse, Service de Medecine Interne et de Gerontologie Clinique, Pavillon Junot, 170 avenue de Casselardit, Hopital La Grave Casselardit, 31300 Toulouse, France
    J Nutr Health Aging 13:679-83. 2009
    ....
  25. doi request reprint Identifying sarcopenia
    Gabor Abellan van Kan
    Gérontopôle de Toulouse, Department of Geriatric Medicine, Toulouse University Hospital bINSERM Unit 1027, University Toulouse III, Toulouse, France
    Curr Opin Clin Nutr Metab Care 15:436-41. 2012
    ..The present review describes and discusses the currently available definitions for sarcopenia from consensus studies...
  26. doi request reprint Cachexia versus sarcopenia
    Yves Rolland
    INSERM U558, University of Toulouse III, France
    Curr Opin Clin Nutr Metab Care 14:15-21. 2011
    ..The review summarizes and discusses the proposed new definitions for sarcopenia and cachexia. It also highlights the overlapping of both conditions and the fact that these conditions frequently occur in elderly patients...
  27. doi request reprint Strontium ranelate and risk of vertebral fractures in frail osteoporotic women
    Yves Rolland
    INSERM U558, F 31073, Avenue Jules Guesdes, University of Toulouse III, F 31073, France
    Bone 48:332-8. 2011
    ..Our study determined and compared the risk of vertebral fractures in frail, intermediate and robust older patients being treated with strontium ranelate vs. placebo...
  28. ncbi request reprint Carla Task Force on Sarcopenia: propositions for clinical trials
    G Abellan Van Kan
    Gerontopole, INSERM U558, University of Toulouse III, Toulouse, France
    J Nutr Health Aging 13:700-7. 2009
    ..Through this report, the reader will appreciate the determination to find conclusions on the various issues and further studies to be developed to determine the best multidisciplinary approach needed...
  29. ncbi request reprint Epidemiology and consequences of sarcopenia
    G Abellan Van Kan
    Gerontopole, Department of Geriatric Medicine, CHU Toulouse, France
    J Nutr Health Aging 13:708-12. 2009
    ..The aim of the present paper was to perform a comprehensive review of the literature on the epidemiology of sarcopenia and its consequences to be presented on November 13th and 14th 2008, at the Carla Workshop...
  30. doi request reprint Physical activity and Alzheimer's disease: from prevention to therapeutic perspectives
    Yves Rolland
    INSERM, Toulouse, France University of Toulouse III, Toulouse, France
    J Am Med Dir Assoc 9:390-405. 2008
    ..In the future, the prevention of Alzheimer's disease may be based on rules governing lifestyle habits such as diet, cognitive activity, and physical activity...
  31. doi request reprint Exceptional bone metastasis of basal cell carcinoma in Gorlin-Goltz syndrome
    Tatiana Lamon
    Gerontopole, Department of Geriatric Medicine, CHU Toulouse, Toulouse, France
    Dermatology 220:57-9. 2010
    ....
  32. ncbi request reprint IANA (International Academy on Nutrition and Aging) Expert Group: weight loss and Alzheimer's disease
    S Gillette Guyonnet
    J Nutr Health Aging 11:38-48. 2007
    ..We will consider four points: the natural history of weight loss, its known etiological factors, its consequences and the various management options...